PERSONAL DETAIL


Ybhg. Prof. Dato' Dr. Adeeba Binti Kamarulzaman

Department of Medicine
Faculty of Medicine
 
  +603-79492050
  adeeba@um.edu.my
  Department of Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, MALAYSIA
 
Homepage
 
ResearcherID Link
  http://www.researcherid.com/rid/B-5216-2010


BIBLIOMETRIC DATA


 Total Articles in Publication List  214
 Articles With Citation Data  214
 Sum of the Times Cited   4934
 Average Citations per Article   23.06
 h-index   34
 Co-authors   Collaboration Network
 This information is generated from http://researcherid.com

BIOGRAPHY


Professor Adeeba Kamarulzaman graduated from Monash University in 1987 and trained in internal medicine and infectious diseases at the Monash Medical Centre and Fairfield Infectious Diseases Hospital, Melbourne, Australia. She is presently the Dean of the Faculty of Medicine, University of Malaya and an Adjunct Associate Professor at Yale University, USA. She established the Centre of Excellence for Research on AIDS (CERiA) that conducts multi-disciplinary research on HIV ranging from clinical to public health and policy research.

Professor Kamarulzaman has used her clinical and academic leadership to engage in the national and community response to HIV/AIDS. She is currently Chairman of the Malaysian AIDS Foundation and an Executive Council member of the Malaysian AIDS Council, the peak HIV NGO in Malaysia.

At the international level, Professor Kamarulzaman is presently an Executive Council Member of the International AIDS Society and a member of the UNAIDS Scientific Expert Panel on HIV. She has also been an advisor to numerous WHO committees on HIV/AIDS. She has played a key role in the establishment and ongoing activities and collaborations of a regional HIV research network initiative; TREAT Asia.

Her achievements have been recognised through several national and international awards including the Tun Mahathir Science and the Merdeka Awards for her role as a member of the University of Malaya’s Nipah Investigative Team. She is the first recipient of the Advance Australia Global Award in the category of Alumni in 2012 and in April 2015 she was honoured with a Doctor of Laws (honoris causa) from her alma mater, Monash University. She also has the distinct honour of having been featured in both The Lancet and Science publications in 2013 and 2014 respectively.

 


ACADEMIC QUALIFICATION
(Qualification), (Institution).



PROFESSIONAL
(Organisation), (Role), (Year), (Level).


  • The Royal Australasian College of Physicians, Fellow, 1995, (International)
  • Asia-Pacific Council of AIDS Service Organisations, Board Member, 2002 to 2007, (International)
  • Malaysian Harm Reduction Working Group, Panel, 2004, (National)
  • Asian Network on Surveillance of Resistant Pathogens (ANSORP), Steering Committee Member, 2005, (International)
  • Treat Asia. Regional Cooperative Network on Research and Therapeutics in HIV/AIDS. Foundation for AIDS Research (amfAR), New York, USA, Steering Committee Member, 2005, (International)
  • UNAIDS Interagency Reference Group for the Technical Support Facility in Southeast Asia and the Pacific, Advisory Board Member, 2006, (University)
  • Global Initiatives Committee, Foundation for AIDS Reasearch (amfAR), New York, USA, Vice Chair, 2006 to 2010, (International)
  • International Harm Reduction Association, Executive Committee Member, 2006, (International)
  • International Harm Reduction Development, Open Society Institute, New York, USA, Advisory Board Member, 2006, (International)
  • United Nations Regional Task Force on HIV Prevention in Injecting Drug Users, Member, 2006, (International)
  • Asia -Pacific Journal of Public Health, Editor, 2006, (International)
  • United Nations Reference Group on HIV and Injecting Drug Use, Member, 2007, (International)
  • Developing World Bioethics, Editor , 2007, (International)
  • Academy of Medicine, Malaysia, Fellow, 2007, (National)
  • INTERNATIONAL JOURNAL OF DRUG POLICY, Editor, 2008, (International)
  • ARV4IDU, Editor, 2008, (International)
  • Scientific/Technical Advisory Group UNAIDS/UNICEF/ADB AIDS Data Hub(STAG), Member, 2008, (International)
  • Oversight Committee for the Second Independant Evaluation of UNAIDS, Member, 2008, (International)
  • International Association for Physicians in AIDS Care, Member, 2008, (International)
  • International AIDS Society, Co-chair, Scientific & Research Sub-commitee, 2008 to 2010, (International)
  • Council Member International Society for Infectious Diseases - 2008, Council Member, 2008, (International)
  • Australasian Society for Infectious Diseases, Member, 2008, (International)
  • Malaysian Society for HIV Medicine , Member, 2008, (National)
  • Malaysian Society for Infectious Diseases and Chemotherapy , Member, 2008, (National)
  • The Lancet Special Series : HIV and Injecting Drug Use , Guest Editor, 2009 to 2010, (International)
  • PLoS ONE, Editorial Board Member, 2010, (International)
  • International Society of Infectious Diseases, Executive Committee Member, 2010 to 2016, (International)
  • Academy of Science, Fellow, 2010, (National)
  • WHO-Strategic and Technical Advisory Committee for HIV-AIDS (STAC-HIV), Co-chair, Scientific & Research Sub-commitee, 2011 to 2012, (International)
  • Programmatic Working Group. WHO Antoretroviral Guidelines Development Group, Co-chair, Scientific & Research Sub-commitee, 2012 to 2013, (International)
  • Johnson& Johnson, Antimicrobials, Regional Advisory Board Member , 2012, (University)
  • International AIDS Society, Governing Council Member, 2012 to 2016, (International)
  • Johnson & Johnson, Virology, Regional Advisory Board Member, 2012, (National)
  • Yale School of Medicine, Associate Adjunct Professor, 2012 to 2017, (International)
  • University Malaya, Ahli Panel Kluster Penyelidikan Health & Translation Medicine, 2013 to 2014, (University)
  • V11th HIV Treatment and Pathogenesis Conference, Kuala Lumpur,2013, Chairperson, 2013, (International)
  • Kementerian Kesihatan Malaysia, Advisory Committee, 2013 to 2014, (National)
  • Dewan Bahasa dan Pustaka, Expert Panel In Medical And Health Sciences, 2013 to 2015, (National)
  • JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, Editorial Board Member, 2013 to 2016, (International)
  • UNAIDS Scientific Expert Panel, Member, 2013 to 2016, (International)
  • Kementerian Kesihatan Malaysia, Member, 2013 to 2016, (National)
  • Ahli Panel Penasihat Pusat Kajian Kecemerlangan Melayu, UM, Panel Member, 2014, (University)
  • Ahli Jawatankuasa Majlis Teknikal Bersama Ijazah Lanjutan Perubatan (MTBILP), Committee Member, 2015 to 2016, (National)
  • Projek Pembangunan Metropolis Perubatan University Malaya, Ajk, Member, 2015 to 2018, (University)
  • PENGERUSI JAWATANKUASA PENASIHAT PERUBATAN PPUM, Chairperson, 2015, (University)
  • Agensi Kelayakan Malaysia (Malaysian Qualification Agency), Pengerusi Jawatankuasa Teknikal, 2015 to 2017, (National)
  • Scientific Steering Committee for Bioinspire Programme , Member, 2016, (University)
  • TULANE UNIVERSITY SCHOOL OF PUBLIC HEALTH AND TROPICAL MEDICINE, Adjacent Professor, 2016 to 2017, (International)
  • Kementerian Kesihatan Malaysia, Council Member, 2017 to 2020, (National)
  • Centre of Innovation & Commercialization (UMCIC) UM, Scientific Committee, 2017 to 2019, (University)
  • Majlis Perubatan Malaysia, Panel Member, 2017 to 2017, (National)
  • World Health Organization, Expert Panel Member, 2017 to 2021, (International)
  • Academy of Medicine Malaysia, Chairperson Of The Amm Education And Training Committee, 2017 to 2018, (National)
  • Ahli Jawatankuasa Pengajian Program Doktor Perubatan, Fakulti Perubatan dan Sains Kesihatan, Committee Member, 2018 to 2021, (National)
  • Merdeka Award Secretariat, Committee, 2018 to 2020, (National)
  • Australasian Society for HIV Medicine, Member, , (International)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).


  • Dean, Dean's Office, Faculty of Medicine, 11/10/2018 to 31/12/2030
  • Menjalankan Fungsi Sebagai Dekan, Dean's Office, Faculty of Medicine, 01/07/2018 to 31/12/2030
  • Dean, Dean's Office, Faculty of Medicine, 01/07/2016 to 30/06/2018
  • Head, Centre of Excellence for Research in Aids (Ceria), Deputy Vice Chancellor(Research & Innovation), 01/01/2016 to 31/12/2017
  • Head, Centre of Excellence for Research in Aids (Ceria), Deputy Vice Chancellor(Research & Innovation), 01/01/2015 to 31/12/2015
  • Dean, Dean's Office, Faculty of Medicine, 01/07/2014 to 30/06/2016
  • Head, Centre of Excellence for Research in Aids (Ceria), Deputy Vice Chancellor(Research & Innovation), 02/01/2014 to 31/12/2014
  • Dean, Dean's Office, Faculty of Medicine, 01/07/2012 to 30/06/2014
  • Dean, Dean's Office, Faculty of Medicine, 01/07/2011 to 30/06/2012
  • Ahli Lembaga Pengurus Pusat Perubatan University Malaya, University Malaya, 20/04/2015
  • Ahli Lembaga Penasihat CIC, University Malaya, 09/02/2015
  • Senate member, University Malaya, University Malaya, 01/08/2010
  • Chair - Infection Control Committee , UMMC, University Malaya, 01/01/2006 to 31/12/2011

AREAS OF EXPERTISE
(Area).


  • Infectious/Communicable Diseases (Specialist In Infectious Diseases NSR)
  • Infectious Disease


RECENT SELECTED PUBLICATIONS
(Publication).


Book

2009
  • Is It HIV ? A handbook for healthcare providers. Australasian Soceity for HIV Medicine & Treat Sia . 2009, Editor 

2004
  • Rapid Situation Assessment of Malaysia 2004, G Reid, A Kamarulzaman, S Kaur . 1-41 
  • University Hospital Antibiotic Policy and Guidelines 2004 - 2006 . Editors A kamarulzaman , N Parasaktthi 

2000
  • Consensus Guidelines on the Management of Staphylococcus aureus infections . Editor A Kamarulzaman . April 2000 

1998
  • 1st National Consensus Guidelines on Antiretroviral Therapy. October 1998 Editors C Lee, A Kamarulzaman, M Alias, N Othman 
Chapter in Book

2016
  • Ng CW, Mohd Hairi NN, Ng CJ, Kamarulzaman A. 2016. Universal Health Coverage in Malaysia: Issues and Challenges. In Tey NP, Cheong KC, Rasiah R (eds). Revisiting Malaysia's Population-Development Nexus. The Past in Its Future. Kuala Lumpur: University of Malaya Press. 

2008
  • A Kamarulzaman, K Razali. The HIV epidemic in Malaysia. Public Health Aspects of HIV/AIDS in Developing Countries: Epidemiology, Prevention and Care. Editors C Beyrer, D Celentano Springer, New York 2008. 

2006
  • A Kamarulzaman. Sepsis. Management aspects of acute care. Eds: Chan YK, Ng KP. 2006:179-187 
  • P du Cros, A Kamarulzaman. HIV and Tuberculosis Coinfection. Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. Editor: M Curtis. International Harm Reduction Development Program. Open Society Institute. 2006 

2002
  • A Kamarulzaman. Common viral infections in Aisa . Principles and Practice of clinical Medicine in Asia. Treating the Asian Patient. Eds : JJY Sung, LKS Wong, PKT Li, J Sanderson, TCY Kwok. 2nd Edn : 2002 

1995
  • A Kamarulzaman, J Hoy. Cryptosporidia and microsporidia. In Fairfield Hospital HIV Handbook. Eds: F Bowden, A Mijch 1995; 43-44 
Article in Academic Journals

2017
  • Naidu Sivaraj, Ponnampalvanar Sasheela, Kamaruzzaman Shahrul Bahyah, and Kamarulzaman Adeeba. Prevalence of Metabolic Syndrome Among People Living with HIV in Developing Countries: A Systematic Review. AIDS Patient Care and STDs. January 2017, 31(1): 1-13. doi:10.1089/apc.2016.0140. (ISI-Indexed)
  • David C Lye, Sophia Archuleta, Sharifah F Syed-Omar, Jenny G Low, Helen M Oh, Yuan Wei, Dale Fisher, Sasheela S L Ponnampalavanar, Limin Wijaya, Linda K Lee, Eng-Eong Ooi, Adeeba Kamarulzaman, Lucy C Lum, Paul A Tambyah, Yee-Sin Leo (2017) . Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial, http://dx.doi.org/10.1016/ S0140-6736(17)30269-6 (ISI-Indexed)
  • Pik San Sit, Cindy Shuan Ju Teh, Nuryana Idris, I-Ching Sam, Sharifah Faridah Syed Omar, Helmi Sulaiman, Kwai Lin Thong, Adeeba Kamarulzaman and Sasheela Ponnampalavanar. (2017). Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia. 17:274.DOI: 10.1186/s12879-017-2384-y (ISI-Indexed)

2016
  • Gender identity, healthcare access, and risk reduction among Malaysia's mak nyah community Britton A. Gibson, Shan-Estelle Brown, Ronnye Rutledge, Jeffrey A. Wickersham, Adeeba Kamarulzaman & Frederick L. Altice (ISI-Indexed)
  • Al-Khannaq MN, Ng KT, Oong XY, Pang YK, Takebe Y, Chook JB, Hanafi NS, Kamarulzaman A, Tee KK. 2016. Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia. Virol J 2016; 13(1):33. (ISI-Indexed)
  • Earnshaw VA, Jin H, Wickersham JA, Kamarulzaman A, John J, Lim SH, and Altice FL. 2016. Stigma Toward Men Who Have Sex with Men Among Future Healthcare Providers in Malaysia: Would More Interpersonal Contact Reduce Prejudice? AIDS and Behavior Jan;20(1):98-106.DOI 10.1007/s10461-015-1168-x (ISI-Indexed)
  • Al-Khannaq, M.N., Ng, K.T., Oong, X.Y., Pang, Y.K., Takebe, Y., Chook, J.B., Hanafi, N.S., Kamarulzaman, A. and Tee, K.K., 2016. Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia.The American journal of tropical medicine and hygiene, pp.15-0810. (ISI-Indexed)
  • Ng KT, Chook JB, Oong XY, Chan YF, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Performance of a Taqman assay for improved detection and quantification of human rhinovirus viral load. Sci Rep 2016; 6:34855. (ISI-Indexed)
  • Chow WZ, Chan YF, Oong XY, Ng LJ, Nor E SS, Ng KT, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes. Sci Rep 2016; 6:27730. (ISI-Indexed)

2015
  • Lucy C. S. Lum, Sharifah Faridah Syed Omar, Sasheela Sri La Sri Ponnampalavanar, Lian H. Tan, Shamala Devi Sekaran, Adeeba Kamarulzaman 2015. Cohorting Dengue Patients Improves the Quality of Care and Clinical Outcome. PLOS Neglected Tropical Diseases. 2015 9(6): e0003836 (ISI-Indexed)
  • Lim, M. K., Lai, P. S., Ponnampalavanar, S. S., Syed Omar, S. F., Taib, N. A., Yusof, M. Y., Italiano, C. M., Kong, D. C. and Kamarulzaman, A. (2015). "Antibiotics in surgical wards: use or misuse? A newly industrialized country's perspective." J Infect Dev Ctries 9(11): 1264-1271. (ISI-Indexed)
  • Tanguay P, Kamarulzaman A, Aramrattana A, Wodak A, Thomson N, Ali R, Vumbaca G, Lai G, Chabungbam A. Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia. (ISI-Indexed)
  • Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, Sabet NS, Sekaran SD, Ponnampalavanar S, Che KF, Velu V, Kamarulzaman A, Larsson M, Shankar EM. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015 Sep;297(1):19-32 (ISI-Indexed)
  • Cheong HT, Chow WZ, Takebe Y, Chook JB, Chan KG, Al- Darraji HA, Koh C, Kamarulzaman A, Tee KK. Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages. PLoS One. 2015 Jul 21;10(7):e0133883. (ISI-Indexed)
  • Jiamsakul A, Chaiwarith R, Durier N, Sirivichayakul S, Kiertiburanakul S, Van Den Eede P, Ditangco R, Kamarulzaman A, Li PC, Ratanasuwan W, Sirisanthana T; TREAT Asia Studies to Evaluate Resistance-Monitoring Study TASER-M. Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals. J Med Virol. 2015 Jul 3. (ISI-Indexed)
  • Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2015 Jul;26(7):675-81. (ISI-Indexed)
  • Bazazi AR, Crawford F, Zelenev A, Heimer R, Kamarulzaman A, Altice FL. HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling. AIDS Behav. 2015 Dec;19(12):2347-57. (ISI-Indexed)
  • Chan KG, Ng KT, Pang YK, Chong TM, Kamarulzaman A, Yin WF, Tee KK. Genome Anatomy of Streptococcus parasanguinis Strain C1A, Isolated from a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Reveals Unusual Genomic Features. Genome Announc. 2015 May 28;3(3) (ISI-Indexed)
  • Tee KK, Kantor R, Sungkanuparph S, Takebe Y, Li P, Ditangco R, Phanuphak P, Sirisanthana T, Sim B, Ratanasuwan W, Kantipong P, Kamarulzaman A. Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia. J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e28-30. (ISI-Indexed)
  • Tien Ng K, Takebe Y, Bee Chook J, Zhen Chow W, Gan Chan K, Abed Al-Darraji HA, Kamarulzaman A, Keng Tee K. Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs. Sci Rep. 2015 Oct 13;5:15198. (ISI-Indexed)
  • Oong XY, Ng KT, Lam TTY, Pang YK, Chan KG, Hanafi NS, Kamarulzaman A, Tee KK. Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014. PloS ONE 2015;10(8), p.e0136254 (ISI-Indexed)
  • Loeliger KB, Marcus R, Wickersham JA, Pillai V, Kamarulzaman A, Altice FL. The syndemic of HIV, HIV-related risk and multiple co- morbidities among women who use drugs in Malaysia: Important targets for intervention. Addict Behav. 2015 Sep 25;53:31-39. (ISI-Indexed)
  • Ng KT, Oong XY, Pang YK, Hanafi NS, Kamarulzaman A, Tee KK. Outbreaks of enterovirus D68 in Malaysia: genetic relatedness to the recent US outbreak strains. Emerging microbes & infections 2015;4(8), p.e47. (ISI-Indexed)
  • Chow WZ, Lim SH, Ong LY, Yong YK, Takebe Y, Kamarulzaman A, Tee KK. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients. PLoS One. 2015 Sep 3;10(9):e0137281. (ISI-Indexed)
  • Wright ST, Law MG, Cooper DA, Keen P, McDonald A, Middleton M, Woolley I, Kelly M, Petoumenos K; Australian HIV Observational Database. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia. J Int AIDS Soc. 2015 Apr 10;18:19463 (ISI-Indexed)
  • Chan KG, Ng KT, Chong TM, Pang YK, Kamarulzaman A, Yin WF, Tee KK. Antibiotic Resistant and Virulence Determinants of Staphylococcus haemolyticus C10A as Revealed by Whole Genome Sequencing. J Genomics. 2015 Jun 3;3:72-4 (ISI-Indexed)
  • Choo MK, El-Bassel N, Adam PC, Gilbert L, Wu E, West BS, Bazazi AR, De Wit JB, Ismail R, Kamarulzaman A. Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen. PLoS One. 2015 Aug 5;10(8):e0118422. (ISI-Indexed)
  • Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, Sabet NS, Sekaran SD, Ponnampalavanar S, Che KF, Velu V, Kamarulzaman A, Larsson M, Shankar EM. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015 Sep;297(1):19-32 (ISI-Indexed)
  • Barathan M, Mohamed R, Saeidi A, Vadivelu J, Chang LY, Gopal K, Ram MR, Ansari AW, Kamarulzaman A, Velu V, Larsson M, Shankar EM. Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease. Eur J Clin Invest. 2015 May;45(5):466-74. (ISI-Indexed)
  • Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC; TREAT Asia HIV Observational Database. Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database. AIDS Patient Care STDS. 2015 May;29(5):229-31.Epub 2015 Mar 16 (ISI-Indexed)
  • Culbert GJ, Waluyo A, Iriyanti M, Muchransyah AP, Kamarulzaman A, Altice FL. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice. Drug Alcohol Depend. 2015 Apr 1;149:71-9. (ISI-Indexed)
  • Oyomopito RA, Chen YJ, Sungkanuparph S, Kantor R, Merati T, Yam WC, Sirisanthana T, Li PC, Kantipong P, Phanuphak P, Lee CK, Kamarulzaman A, Ditangco R, Huang SW, Sohn AH, Law M, Chen YM. Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B. Kaohsiung J Med Sci. 2015 Sep;31(9):445-53. (ISI-Indexed)
  • Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M; TREAT Asia HIV Observational Database. Tenofovir-based antiretroviral therapy in HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antivir Ther. 2015 Jun 12 (ISI-Indexed)
  • Ansari AW, Ahmad F, Meyer-Olson D, Kamarulzaman A, Jacobs R, Schmidt RE. Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis. Cell Mol Life Sci. 2015 Aug;72(16):3037-49 (ISI-Indexed)
  • Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Databases (TAHOD). Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):e85-92 (ISI-Indexed)
  • Al-Darraji HA, Tan C, Kamarulzaman A, Altice FL. Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia. Occup Environ Med. 2015 Jun;72(6):442-7. (ISI-Indexed)
  • Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abuse Treat. 2015 Jul;54:29-36. (ISI-Indexed)

2014
  • Hong Yien Tan, Yean Kong Yong, Sin How Lim, Sasheela Ponnampalavanar, Sharifah F. S. Omar, Yong Kek Pang, Adeeba Kamarulzaman, Patricia Price, Suzanne M. Crowe and Martyn A. French. 2014. Tuberculosis (TB)- associated immune reconstitution inflammatory syndrome in TB-HIV co- infected patients in Malaysia: prevalence, risk factors, and treatment outcomes. Sexual Health 2014 September; DOI: 10.1071/SH14093 (ISI-Indexed)
  • Harry Jin, Valerie A. Earnshaw, Jeffrey A. Wickersham, Adeeba Kamarulzaman, Mayur M. Desai, Jacob John & Frederick L. Altice 2014. An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV,DOI: 10.1080/09540121.2014.894616 (ISI/SCOPUS Indexed Publication)

2013
  • Larsson M, Shankar EM, Che KF, Saeidi A, Elleg� R, Barathan M, Velu V, Kamarulzaman A. 
  • Chow WZ, Ong LY, Razak SH, Lee YM, Ng KT, Yong YK, Azmel A, Takebe Y, Al-Darraji HA, Kamarulzaman A, Tee KK 
  • Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A 
  • Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li PC, Kantipong P, Lee C, Ratanasuwan W, Kamarulzaman A, Sohn AH, Sungkanuparph S; for the TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies. 
  • Wickersham JA,Zahari MM,Azar MM,Kamarulzaman A,Altice FL 
  • Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros P, Ford N. 
  • Kamarulzaman A 
  • Lubis R, Bulgiba A, Kamarulzaman A, Hairi NN, Dahlui M, Peramalah D 
  • Ng KT, Lee YM, Al-Darraji HA, Xia X, Takebe Y, Chan KG, Lu L, Mahadeva S, Kamarulzaman A, Tee KK. 
  • Mohd Zim MA, Sam IC, Omar SF, Cahn YF,Abu Bakar S,Kamarulzaman A. Chikungunya infection in Malaysia:Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol.2013 
  • Lee SS, Meintjes G, Kamarulzaman A, Leung CC 
  • Abed Al-Darraji HA, Abd Razak H, Ng KP, Altice FL, Kamarulzaman A 
  • Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia- Pacific HIV Observational Database (APHOD). 
  • Lim SH, Bazazi AR, Sim C, Choo M, Altice FL, Kamarulzaman A 
  • Ng KT, Ong LY, Lim SH, Takebe Y, Kamarulzaman A, Tee KK 
  • Reena Rajasuriara,Gabriela Khouryc,Adeeba Kamarulzaman, Martyn A. Frenche,Paul U.Cameronc,and Sharon R. Lewinc 

2012
  • Chow WZ, Al-Darraji H, Lee YM, Takebe Y, Kamarulzaman A, Tee KK. 
  • Smolak A, Gorroochurn P, Kamarulzaman A, Janjua N 
  • Ng KT, OngLY, Takabe Y, Kamarulzaman A, Tee KK, 
  • Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance 
  • Ford N, Kirby C, Singh K, Mills EJ, Cooke G, Kamarulzaman A,duCros P. 
  • Chong YB, Tan LP, Robinson S, Lim SK, Ng KP, Keng TC, Kamarulzaman A. Penicilliosis in lupus patients presenting with unresolved fever: A report of 2 cases and literature review. Tropical Biomedicine 29(2):270- 276 (2012) (ISI-Indexed)
  • Tee KK, Kamarulzaman A, Matano T, Takebe Y. Future Virol. (2012) 7(4), 405-414 (ISI-Indexed)
  • Azzoni L, Foulkes AS, Liu Y, Li X, Johnson M, Smith C, Kamarulzaman AB, Montaner J, Mounzer K, Saag M, Cahn P, Cesar C, Krolewiecki A, Sanne I, Montaner LJ. PLoS Med. 2012;9(4):e1001207. Epub 2012 Apr 17. (ISI-Indexed)
  • Ford N, Singh K, Cooke GS, Mills EJ, von Schoen- Angerer T, Kamarulzaman A, du Cros P. Clin Infect Dis. 2012 May;54(10):1465-72. Epub 2012 Mar 19. (ISI-Indexed)
  • Al-Darraji HA, Kamarulzaman A, Altice FL. Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9. Epub 2012 Mar 7. (ISI-Indexed)
  • Zhou J, Tanuma J, Chaiwarith R, Lee CK, Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari S, Choi JY, Parwati Merati T, Yunihastuti E, Li PC, Kamarulzaman A, Nguyen VK, Thuy Pham TT, Lim PL. AIDS Res Treat. 2012;2012:375217. Epub 2012 Feb 22. (ISI-Indexed)
  • Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database. J Int AIDS Soc. 2012 Jan 26;15(1):1. (ISI-Indexed)
  • Aghafar MZ, Witt C, Kamarulzaman A, Ismail R, Lederman MM, Rodriguez B, Senitzer D, Lee S, Price P. Tissue Antigens.¿2012 May;79(5):367-71. doi: 10.1111/j.1399-0039.2012.01843.x. Epub 2012 Feb 2. (ISI-Indexed)
  • Jeffrey A Wickersham,Ruthanne Marcus,Adeeba Kamarulzaman, Muhammad Muhsin Zaharib & Frederick L Altice 
  • Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; On behalf of the TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M). Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-na HIV-infected patients in Asia: TASER-M cohort analysis. BMC Res Notes. 2012 Oct 24;5(1):582. 
  • Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; on behalf of the TREAT Asia Studies to Evaluate Resistance (TASER) and the TREAT Asia HIV Observational Database. Evaluating immunologic response and clinical deterioration in treatment-na� patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr. 2012 Nov 7 
  • Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249. doi: 10.1371/journal.pone.0044249. Epub 2012 Sep 18. 
  • Sam IC, Karunakaran R, Kamarulzaman A, Ponnampalavanar S, Syed Omar SF, Ng KP, Mohd Yusof MY, Hooi PS, Jafar FL, Abubakar S. A large exposure to Brucella melitensis in a diagnostic laboratory. J Hosp Infect 2012; 80(4):321-5. (ISI-Indexed)

2011
  • Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M). HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis. 2011 Apr 15;52(8):1053-7. 
  • Kanter J, Koh C, Razali K, Tai R, Izenberg J, Rajan L, Van Griensven F, Kamarulzaman A. Risk behaviour and HIV prevalence among men who have sex with men in a multiethnic society: a venue-based study in Kuala Lumpur, Malaysia. Int J STD AIDS. 2011 Jan;22(1):30-7. 
  • Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug Alcohol Depend. 2011 Jan 11. 
  • Tan DB, Yong YK, Lim A, Tan HY, Kamarulzaman A, French M, Price P. Robust interferon-¿nd IL-12 responses by dendritic cells are related to efficient CD4(+) T-cell recovery in HIV patients on ART. Clin Immunol. 2011May;139(2):115-21. Epub 2011 Feb 23 
  • Tan LH, Fong MY, Mahmud R, Muslim A, Lau YL, Kamarulzaman A. (2011). Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia. Parasitol Int 60: 111-113 (ISI-Indexed)
  • Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French M, Price P. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS. 2011 Jul 31;25(12):1455-60 

2010
  • Adeeba Kamaruzzaman & Shaikh Mohd Saifuddeen. 2010. Islam and harm reduction. International Journal of Drug Policy 21(2): 115-118. (ISI-Indexed)
  • Tan DBA, Yong YK, Tan HY, French M, Kamarulzaman A, et al. (2010) Characteristics of Natural Killer Cells in Malaysian HIV Patients Presenting with Immune Restoration Disease After ART. J AIDS Clinic Res 1:102 doi:10.4172/2155-6113.1000102 
  • Chew CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S,Ismail R, Phipps M, Aghafar Z, Gut I, Price P. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and caucasian human immunodeficiency virus patients. Tissue Antigens. 2010 Sep 30.doi: 10.1111/j.1399- 0039.2010.01570.x. [Epub ahead of print] PubMed PMID: 20887379 
  • CE Lee, K Adeeba, G Freigang Human Plasmodium Knolesi Infections in Klang Valley, Peninsula Malaysia : A Case Series Med J Mal Vol 65 No 1 , March 2010 
  • Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010 Jun;21 (6):416-23 
  • Kamarulzaman A, Saifuddeen SM. Islam and harm reduction. Int J Drug Policy. 2010 Mar;21(2):115-8. Epub 2009 Dec 16. 
  • Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY, Takebe Y, Pybus OG. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010 Apr;84(7):3339-50. Epub 2010 Jan 20. 
  • Li Y, Tee KK, Liao H, Hase S, Uenishi R, Li XJ, Tsuchiura T, Yang R, Govindasamy S, Yong YK, Tan HY, Pybus OG, Kamarulzaman A, Takebe Y. Identification of a Novel Second- Generation Circulating Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. J Acquir Immune Defic Syndr. 2010 Apr 7. 
  • Takebe Y, Liao H, Hase S, Uenishi R, Li Y, Li XJ, Han X, Shang H, Kamarulzaman A, Yamamoto N, Pybus OG, Tee KK. Reconstructing the chronology of the expansion of HIV-1 in East Asia: the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC. Vaccine. 2010 May 26;28 Suppl 2:B39-44. 
  • Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J,Sirisanthana T, Chen YM, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; on behalf of The TREAT Asia HIV Observational Databse. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2010 Mar 21 
  • Lau KA, Wang B, Miranda-Saksena M, Boadle R, Kamarulzaman A, Ng KP, Saksena NK. Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B. Curr HIV Res. 2010 Apr 1;8(3):259-71. 
  • Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010 Mar 20;375(9719):1014-28. 
  • Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to Act : a call for comprehensive responses to HIV in people who use drugs.Lancet.2010Jul 20 
  • Altice FL,Kamarulzaman A, Soriano W,Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010 Jul 31;376(9738):367-87 
  • Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 myths about HIV/AIDS and people who use drugs. Lancet . 2010 Jul 24;376(9737):208-11 
  • Sam, I-C., Kamarulzaman, A., Ong, G.S.Y., Veriah, R.S., Ponnampalavanar, S., Chan, Y.F. and AbuBakar, S. 2010. Chikungunya virus-associated death in Malaysia. Tropical Biomedicine 27(2): 343¿347 (2010) (ISI-Indexed)
  • Bux SI, Mohd. Ramli N, Ahmad Sarji S, Kamarulzaman A CHEST IMAGING FEATURES OF PATIENTS AFFLICTED WITH INFLUENZA A (H1N1) IN A MALAYSIAN TERTIARY REFERRAL CENTRE Biomed Imaging Interv J 2010; 6(4):e35 (SCOPUS-Indexed)
  • Fong, M. Y., Wong, K. T., Rohela, M., Tan, L. H., Adeeba, K., Lee, Y. Y., Lau, Y. L., et al. 2010. Unusual manifestation of cutaneous toxoplasmosis in a HIV-positive patient Tropical Biomedicine. (Tier 4, Impact Factor = 0.649) (ISI-Indexed)
  • Zhou, J. L., Sirisanthana, T., Kiertiburanakul, S., ..., Kamarulzaman, A., et al. 2010. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database Bmc Infectious Diseases. (Tier 2, Impact Factor = 2.55) (ISI-Indexed)
  • Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., Friedland, G. H. 2010. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs Lancet. (Tier 1, Impact Factor = 30.758) (ISI-Indexed)
  • Takebe, Y., Liao, H. N., Hase, S., Uenishi, R., Li, Y. E., Li, X. J., Kamarulzaman, A., Tee, K. K., et al. 2010. Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: The relevance of genetic diversity and phylodynamics for vaccine strategies Vaccine. (Tier 1, Impact Factor = 3.616) (ISI-Indexed)
  • Yue Li, BSc,Kok Keng Tee, PhD,Huanan Liao,PhD,Saiki Hase, PhD,Rie Uenishi,PhD,Xiao-Jie Li, MD, PhD,Takayo Tsuchiura, BSc,Rongge Yang, MD, PhD,Sumathi Govindasamy, BA,Yean Kong Yong, MMedSc, Hong Yien Tan, MMedSc,Oliver G. Pybus, PhD,k Adeeba Kamarulzaman,MBBS, FRACP,and Yutaka Takebe, MD, PhD.Identification of a Novel Second-Generation Circulating .Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. Feb 2010 
  • Zahari, M. M., Bae, W. H., Zainal, N. Z., Habil, H., Kamarulzaman, A., Altice, F. L. 2010. Psychiatric and Substance Abuse Comorbidity among HIV Seropositive and HIV Seronegative Prisoners in Malaysia American Journal of Drug and Alcohol Abuse. (Tier 2, Impact Factor = 1.335) (ISI-Indexed)
  • Zahari MM, Bae WH, Zainal NZ, Habil H, Kamarulzaman A, Altice FL.Psychiatric and Substance Abuse Co-Morbidity Among HIV Seropositive and HIV Seronegative Prisoners in Malaysi. Am J Drug Alcohol Abuse.Jan;36(1);31-8 
  • Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, Kamarulzaman A, Wong MH, Syed Omar SF, Hussain SH. High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. J Infect. 2010 Aug 11. (ISI-Indexed)

2009
  • Tee KK, Pybus OG, Parker J, Ng KP, Kamarulzaman A, Takebe Y.Estimating the date of origin of an HIV-1 circulating recombinant form.Virology. 2009 Mar 7. 
  • Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009 Jul 28;73(4):315-20. 
  • Benito N, Mir¿ JM, de Lazzari E, Cabell CH, del R¿A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009 May 5;150(9):586-94 (ISI-Indexed)
  • Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV- infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis. 2009 Apr 1;48(7):940-50 (ISI-Indexed)
  • Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kone¿ P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Mir¿ JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008 Oct 27;168(19):2095-103 (ISI-Indexed)
  • Cherry, C. L., Affandi, J. S., Imran, D., Yunihastuti, E., Smyth, K., Vanar, S., Kamarulzaman, A., Price, P. 2009. Age and height predict neuropathy risk in patients with HIV prescribed stavudine Neurology. (Tier 1, Impact Factor = 7.043) (ISI-Indexed)
  • Tee, K. K., Takebe, Y., Kamarulzaman, A. 2009. Emerging and re-emerging viruses in Malaysia, 1997-2007 International Journal of Infectious Diseases. (Tier 3, Impact Factor = 2.210) (ISI-Indexed)
  • Tee, K. K., Pybus, O. G., Parker, J., Ng, K. P., Kamarulzaman, A., Takebe, Y. 2009. Estimating the date of origin of an HIV-1 circulating recombinant form Virology. (Tier 2, Impact Factor = 3.539) (ISI-Indexed)
  • Benito, N., Miro, J. M., de Lazzari, E., ..., Kamarulzaman, A., et al. 2009. Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition Annals of Internal Medicine. (Tier 1, Impact Factor = 17.457) (ISI-Indexed)
  • Srasuebkul, P., Lim, P. L., Lee, M. P., ..., Kamarulzaman, A., et al. 2009. Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT Asia HIV Observational Database Clinical Infectious Diseases. (Tier 1, Impact Factor = 8.266) (ISI-Indexed)
  • Kamarulzaman, A. 2009. Impact of HIV Prevention Programs on Drug Users in Malaysia Jaids-Journal of Acquired Immune Deficiency Syndromes. (Tier 1, Impact Factor = 4.57) (ISI-Indexed)
  • Egger, S., Petoumenos, K., Kamarulzaman, A., Hoy, J., Sungkanuparph, S., Chutah, J., Falster, K., Zhou, J. L., Law, M. G. 2009. Long-Term Patterns in CD4 Response Are Determined by an Interaction Between Baseline CD4 Cell Count, Viral Load, and Time: The Asia Pacific HIV Observational Database (APHOD) Jaids-Journal of Acquired Immune Deficiency Syndromes. (Tier 1, Impact Factor = 4.57) (ISI-Indexed)
  • Zhou, J. L., Elliott, J., Li, P. C. K., ..., Kamarulzaman, A., et al. 2009. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database Bmc Infectious Diseases. (Tier 2, Impact Factor = 2.536) (ISI-Indexed)
  • Bruce, R. D., Govindasamy, S., Sylla, L., Kamarulzaman, A., Altice, F. L. 2009. Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market American Journal of Drug and Alcohol Abuse. (Tier 3, Impact Factor = 1.094) (ISI-Indexed)
  • Kamarulzaman A, Impact of HIV Prevention Programs on Drug Users in Malaysia . J Acquir Immune Defic Syndr .Nov;52 Suppl 1;S17-9 
  • Kamarulzaman A, Antiretroviral therapy in Malaysia; identifying barriers to universal access HIV Therapy. Nov , Vol. 3, No. 6, Pages 573-582 
  • Tee KK, Kusagawa S, Li XJ, Onogi N, Isogai M, Hase S, Uenishi R, Liao H, Kamarulzaman A, Takebe Y. Isolation and characterization of a replication- competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B)PLoS One. Aug 18;4 (8). 
  • Tee KK, Takebe Y, Kamarulzaman A. Emerging and re- emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2009 May;13(3):307-18. 

2008
  • Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2008 Nov 13 
  • Wright E, Brew B, Arayawichanont A, Robertson k, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffman S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, dwyer R, McCormack G, Hellard M, Cherry C, Mc Arthur J, Wesselingh S. Neurologic Disorders are Prevalent in HIV-posotive Outpatients in the Asia-Pacific Region. Neurology. 2008 Jul 1;71(1):50-6. 
  • Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kamarulzaman A, Konecny P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Miro JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med. 2008 Oct 27; 168(19):2095-103 
  • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Near full-length sequence analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia. AIDS Res Hum Retroviruses. 2007 Sep;23(9):1139-45. 
  • Tee KK, Pybus OG, Li XJ, Han X, Shang H, Kamarulzaman A, Takebe Y. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J Virol. 2008 Sep;82(18):9206-15. 
  • Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP; 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008 Nov 15;372(9651):1733-45 
  • Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, James I, French M, Price P. Immunological Profiles of Immune Restoration Disease Presenting as Mycobacterial Lymphadenitis and Cryptococcal Meningitis. HIV Med. 2008 May;9(5):307-16 
  • Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altics FL. Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia. AM J Drug Alcohol Abuse. 2008;24(4):511-7 
  • 33. Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 
  • Baskaran, N. D., Gan, G. G., Adeeba, K. 2008. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients Annals of Hematology. (Tier 2, Impact Factor = 2.342) (ISI-Indexed)
  • Bruce, R. D., Govindasamy, S., Sylla, L., Haddad, M. S., Kamarulzaman, A., Altice, F. L. 2008. Case series of buprenorphine injectors in Kuala Lumpur, Malaysia American Journal of Drug and Alcohol Abuse. (Tier 2, Impact Factor = 1.236) (ISI-Indexed)
  • Tee, K. K., Pybus, O. G., Liao, H., Uenishi, R., Hase, S., Kamarulzaman, A., et al. 2008. Chronology of the HIV-1CRF07_BC expansion in East Asia Aids. (Tier 1, Impact Factor = 5.842) (ISI-Indexed)
  • Lau, K. A., Wang, B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2008. Continuous crossover(s) events of HIV-1CRF01_AE and B subtype strains in Malaysia: Evidence of rapid and extensive HIV-1 evolution in the region Current Hiv Research. (Tier 2, Impact Factor = 2.653) (ISI-Indexed)
  • Tan, D., Yong, Y., Tan, H., Kamarulzaman, A., Tan, L., Lim, A., et al. 2008. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis Hiv Medicine. (Tier 1, Impact Factor = 3.347) (ISI-Indexed)
  • Wright, E., Brew, B., Arayawichanont, A., Robertson, K., Samintharapanya, K., Kongsaengdao, S., et al. 2008. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region Neurology. (Tier 1, Impact Factor = 6.014) (ISI-Indexed)
  • Tee, K. K., Pybus, O. G., Li, X. J., Han, X. X., Shang, H., Kamarulzaman, A., et al. 2008. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia Journal of Virology. (Tier 1, Impact Factor = 5.332) (ISI-Indexed)
  • Sherman, S. G., Kamarulzaman, A., Spittal, P. 2008. Women and drugs across the globe: A call to action International Journal of Drug Policy. (Tier 2, Impact Factor = 1.272) (ISI-Indexed)
  • Sherman SG, Kamarulzaman A, Spittal P.Women and drugs across the globe: a call to action. Int J Drug Policy. 2008 Apr;19(2):97-8. 
  • Baddley JW, Benjamin DK Jr, Patel M, Mir J, Athan E, Barsic B, Bouza E,Clara L, Elliott T, Kanafani Z, Klein J, Lerakis S, Levine D, Spelman D,Rubinstein E, Tornos P, Morris AJ, Pappas P, Fowler VG Jr, Chu VH, Cabell C; International Collaboration on Endocarditis- Prospective Cohort Study Group (ICE - PCS).Eur J Clin Microbiol Infect . Candida infective endocarditis. Dis. 2008 Jul;27(7):519-29. 
  • Tee KK, Pybus OG, Liao H, Uenishi R, Hase S, Kamarulzaman A, Li XJ, Takebe Y.Chronology of the HIV- 1 CRF07_BC expansion in East Asia. AIDS. 2008 Jan 2;22(1):156-8. 
  • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 

2007
  • Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007 Aug;18(4):306-12 
  • Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug Policy. 2007 Mar;18(2):136-40 
  • Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS. 2007 Jul 31;21(12):1525-34. 
  • Todd CS, Nassiramanesh B, Stanekzai MR, Kamarulzaman A. Emerging HIV Epidemics in Muslim Countries: Assessment of Different Cultural Responses to Harm Reduction and Implications for HIV Control. Cur HIV/AIDS Rep. 2007 Dec;4(4):151-7 
  • Lim, A., Tan, D., Price, P., Kamarulzaman, A., Tan, H. Y., James, I., French, M. A. 2007. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy Aids (ISI-Indexed)
  • Lau, K. A., Wang, B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2007. Near full-length sequence analysis of a unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia Aids Research and Human Retroviruses (ISI-Indexed)
  • Reid, G., Kamarulzaman, A., Sran, S. K. 2007. Malaysia and harm reduction: The challenges and responses International Journal of Drug Policy (ISI-Indexed)
  • Zhou, J., Paton, N. I., Ditangco, R., Chen, Y. M., Kamarulzaman, A., Kumarasamy, N., Lee, C. K. C., Li, P. C. K., Merati, T. P., Phanuphak, P., Pujari, S., Vibhagool, A., Zhang, F., Chuah, J., Frost, K. R., Cooper, D. A., Law, M. G. 2007. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database Hiv Medicine (ISI-Indexed)
  • Baskaran, N. D., Gan, G. G., Adeeba, K., Sam, I. C. 2007. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia International Journal of Infectious Diseases (ISI-Indexed)
  • Wang, B., Lau, K. A., Ong, L. Y., Shah, M., Steam, M. C., Foley, B., Dwyer, D. E., Chew, C. B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2007. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants Virology (ISI-Indexed)
  • Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med. 2007 Jan;8(1):8-16. 
  • Wang B, Lau KA, Ong LY, Shah M, Steain MC, Foley B, Dwyer DE, Chew CB, Kamarulzaman A, Ng KP, Saksena NK. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. Virology. 2007 Oct 25;367(2):288-97. 

2006
  • Tee KK, Kamarulzaman A, Ng KP. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. Med Microbiol Immunol. 2006 Jun;195(2):107-12. 
  • Tee KK, Li XJ, Nohtomi K, Ng KP, Kamarulzaman A, Takebe Y. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):523-9. 
  • Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses. 2006 Feb;22(2):121-4. 
  • Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. J Postgrad Med. 2006 Jan-Mar;52(1):23-9; 
  • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16 
  • Tee, K. K., Li, X. J., Nohtomi, K., Ng, K. P., Kamarulzaman, A., Takebe, Y. 2006. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
  • Zhou, M. L., Phanupak, P., Kiertiburanakul, S., Ditangco, R., Kamarulzaman, A., Pujary, S., et al. 2006. Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
  • Tee, K. K., Kamarulzaman, A., Ng, K. P. 2006. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia Medical Microbiology and Immunology (ISI-Indexed)
  • Raja, N. S., Parasakthi, N., Puthucheary, S. D., Kamarulzaman, A. 2006. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia Journal of Postgraduate Medicine (ISI-Indexed)
  • Tee, K. K., Kamarulzaman, A., Ng, K. P. 2006. Low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia Aids Research and Human Retroviruses (ISI-Indexed)

2005
  • Joazlina ZY, Wastie ML, Kamarulzaman A. Kostmann\'s syndrome. Clin Imaging. 2005 Sep-Oct;29(5):364-6. 
  • Hughes AJ, Ariffin N, Huat TL, Abdul Molok H, Hashim S, Sarijo J, Abd Latif NH, Abu Hanifah Y, Kamarulzaman A. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol. 2005 Jan;26(1):100-4. 
  • Nurul Atifah MA, Loo HK, Subramaniam G, Wong EH, Selvi P, Ho SE, Kamarulzaman A, Parasakthi N. Faecal prevalence of extended-spectrum Beta-lactamase (ESBL)-producing coliforms in a geriatric population and among haematology patients. Malays J Pathol. 2005 Dec;27(2):75-81. 
  • Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50. 
  • Adeeba Kamarulzaman .Taking stock of two decades of the HIV/AIDS epidemic in Malaysia. 2005, Med. J. Malaysia, Vol. 60, no. 1, pg. 1-4 
  • Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG, The TREAT Asia HIV Observational Database: Baseline and Retrospective Data, 2005, J. Acquir. Immune Defic. Syndr., Vol. 138, no. 2, pg. 174-179 
  • Tee KK, Pon CK, Kamarulzaman A, Ng KP. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS. 2005 Jan 28;19(2):119-26. 
  • Ranganathan S, Moosa F, Kamarulzaman A, Looi LM. MRI and CT findings of cryptococcal vaginitis. 2005, Br. J. Radiol., Vol. 78, no. 928, pg. 353-354 
  • Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50. 
  • Tee, K. K., Saw, T. L., Pon, C. K., Kamarulzaman, A., Ng, K. P. 2005. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia Aids Research and Human Retroviruses (ISI-Indexed)
  • Ranganathan, S., Moosa, F., Kamarulzaman, A., Looi, L. M. 2005. MRI and CT findings of cryptococcal vaginitis British Journal of Radiology (ISI-Indexed)
  • Zhou, J., Kumarasamy, N., Ditangco, R., Kamarulzaman, A., Lee, C. K. C., Li, P. C. K., et al. 2005. The TREAT Asia HIV observational database - Baseline and retrospective data Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
  • Tee, K. K., Pon, C. K., Kamarulzaman, A., Ng, K. P. 2005. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia Aids (ISI-Indexed)
  • Joazlina, Z. Y., Wastie, M. L., Kamarulzaman, A. 2005. Kostmanns syndrome Clinical Imaging (ISI-Indexed)
  • Vinothini. A, Khoo, E.M. & Adeeba, K. 2005. Knowledge of HIV/AIDs in among pregnant women in an urban health clinic - a preliminary study. The Family Physician 13(1&2): 10-15 (Non-ISI/Non-SCOPUS)

2004
  • Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, Chang HH, Kim SW, Lee H, Kim YS, Oh WS, Peck KR, Chongthaleong A, Lalitha MK, Perera J, Yee TT, Jamal F, Kamarulzaman A, Carlos CC, So T; Asian Network for Surveillance of Resistant Pathogens Study Group. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis. 2004 Jun 1;38(11):1570-8 
  • Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, Lee NY, Yang Y, Lu Q, Chongthaleong A, Chiu CH, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Jamal F, Kamarulzaman A, Parasakthi N, Van PH, Carlos C, So T, Ng TK, Shibl A. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004 Jun;48(6):2101-7. 
  • Oh WS, Suh JY, Song JH, Ko KS, Jung SI, Peck KR, Lee NY, Yang Y, Chongthaleong A, Chiu CH, Kamarulzaman A, Parasakthi N, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Carlos CC; ANSORP Study Group. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb Drug Resist. 2004 Spring;10(1):37-42 
  • Kamarulzaman A. Tackling infectious diseases threats in the Asia-Pacific through regional and international collaboration. Asia Pac J Public Healt. 2004;16(1):1-2 

2002
  • Tan YM, Goh KL, Kamarulzaman A, Tan PS, Ranjeev P, Salem O, Vasudevan AE, Rosaida MS, Rosmawati M, Tan LH. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002 Feb;55(2):276-8. 
  • Tan LH, Kamarulzaman A, Liam CK, Lee TC. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. Infect Control Hosp Epidemiol. 2002 Oct;23(10):584-90. 
  • Gan GG, Kamarulzaman A, Goh KY, Ng KP, Na SL, Soo-Hoo TS. Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient. Med J Malaysia. 2002 Mar;57(1):118-22. 
  • Nissapatorn V, Kamarulzaman A, Init I, Tan LH, Rohela M, Norliza A, Chan LL, Latt HM, Anuar AK, Quek KF. Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors. Med J Malaysia. 2002 Sep;57(3):304-10. 
  • Tan, L. H., Kamarulzaman, A., Liam, C. K., Lee, T. C. 2002. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia Infection Control and Hospital Epidemiology (ISI-Indexed)
  • Tan, Y. M., Goh, K. L., Kamarulzaman, A., Tan, P. S., Ranjeev, P., Salem, O., et al. 2002. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate Gastrointestinal Endoscopy (ISI-Indexed)

2001
  • Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan SR, Chew NK, Chua KB, Lam SK. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001 Jun;49(6):810-3. 
  • Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, Kamarulzaman A, Olson J, Tan CT. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect. 2001 Jan;42(1):40-3. 
  • Chong, H. T., Kamarulzaman, A., Tan, C. T., Goh, K. J., Thayaparan, T., Kunjapan, R., Chew, N. K., Chua, K. B., Lam, S. K. 2001. Treatment of acute Nipah encephalitis with ribavirin Annals of Neurology (ISI-Indexed)
  • Chua, K. B., Lam, S. K., Goh, K. J., Hooi, P. S., Ksiazek, T. G., Kamarulzaman, A., Olson, J., Tan, C. T. 2001. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia Journal of Infection (ISI-Indexed)

2000
  • Chua KB, Lam SK, Tan CT, Hooi PS, Goh KJ, Chew NK, Tan KS, Kamarulzaman A, Wong KT. High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid. Ann Neurol. 2000 Nov;48(5):802-5. 
  • Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000 Apr 27;342(17):1229-35. 
  • Tan SY, Tan LH, Teo SM, Thiruventhiran T, Kamarulzaman A, Hoh HB. Disseminated nocardiosis with bilateral intraocular involvement in a renal allograft patient. Transplant Proc. 2000 Nov;32(7):1965-6. 
  • Goh, K. J., Tan, C. T., Chew, N. K., Tan, P. S. K., Kamarulzaman, A., Sarji, S. A., et al. 2000. Clinical features of nipah virus encephalitis among pig farmers in Malaysia New England Journal of Medicine (ISI-Indexed)

1999
  • Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999 Oct 9;354(9186):1257-9 
  • Pakianathan MR, Kamarulzaman A, Ismail R, McMillan A, Scott GR. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients. AIDS. 1999 Sep 10;13(13):1787-8. No abstract available 
  • Pakianathan, M. R., Kamarulzaman, A., Ismail, R., McMillan, A., Scott, G. R. 1999. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients Aids (ISI-Indexed)
  • Chua, K. B., Goh, K. J., Wong, K. T., Kamarulzaman, A., Tan, P. S. K., Ksiazek, T. G., et al. 1999. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia Lancet (ISI-Indexed)

1996
  • Kamarulzaman A, Briggs RJ, Fabinyi G, Richards MJ. Skull osteomyelitis due to Salmonella species: two case reports and review. Clin Infect Dis. 1996 Apr;22(4):638-41. 
Proceeding
Mass Media(Newspaper,Radio,Tv,Popular Magazine)

2015
  • Her World Power list: 6 most inspiring women of Singapore and Malaysia 
  • Malay Mail - Monash Honarary Doctorate Award 
  • Rawatan penagih lebih baik di luar penjara 

2014
  • Metro Ahad / Karisma 

2013
  • Adeeba Kamarulzaman and Bertrand Union . Winds of change on drug policy 
  • Adeeba Kamarulzaman. Penghidap HIV turun 
  • AN EVENING OF GLAMOUR AND GOODWILL THE MALAYSIAN AIDS COUNCIL ANNUAL 
  • THE THIN RED LINE 
  • FRONTLINER FOR HIV AIDS PROFESSOR DR ADEEBA KAMARULZAMAN ON THE CAUSE CLOSE TO HER HEART 
  • The female face of HIV/AIDS 
  • Foundation receives RM25,000 - NST 
  • Adeeba Kamarulzaman,Reena Rajasuriar 

2012
  • New York Times : Towards an AIDS-Free World 
Others

1999
  • A Kamarulzaman, KJ Goh. Causes of viral encephalitis outbreaks in Malaysia and Australia. In UptoDate. Eds JG Bartlett, SB Calderwood, MS Hirsch, et al. 1999 

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).


  • The relationship between lipodystrophy, insulin resistance, adiponectin levels and their association with subclinical atherosclerosis in aging HIV patients compared to the non HIV population., Consultant, 2015 - 2017, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science), (University)
  • Review Of Policy Towards Healthy Lifestyles, Consultant, 2015 - 2017, RU Operation, (National)
  • The Impact Of The Changing Genotypic And Phenpotypic Trends Of Methicillin-resistant Staphylococcus Aureus (mrsa) Infection In A Tertiary Teaching Hospital- A 5 Year Cohort Study, Consultant, 2014 - 2018, Fundamental Research Grant Scheme (FRGS), (National)
  • Free circulating mitochondrial DNA and its association with tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS), Consultant, 2014 - 2015, Research Officer Grant Scheme (ROGS), (National)
  • Demographic Network Modelling Of The Spread Of Infectious Diseases, Consultant, 2013 - 2017, Geran Penyelidikan Universiti Malaya (UMRG Programme) - SBS (Equitable Society), (University)
  • Optimization Of Biochemical And Functional Interaction Between Hiv-1 Tat Protein And Rna Aptamer, Principal Investigator(PI), 2013 - 2016, Program Rakan Penyelidikan - RACE, (National)
  • Adult Dengue Platelet Study (ADEPT), Co-Investigator, 2013 - 2015, National Medical Research Council (NMRC) Singapore, (International)
  • Molecular Genetics of Respiratory Pathogens Associated with Respiratory Tract Infections (From January 2012) High Impact Research (HIR): Genetics of the Respiratory, Gastrointestinal, Central Nervous System and Blood-borne Pathogens, Co-Investigator, 2012 - 2014, High Impact Research (HIR), (International)
  • Investigations On Regulatory Molecules In T Cells Of Antiretroviral Therapy (art) Naive And Treated Hiv-1 Infected Individuals, Consultant, 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Evaluation of an Antimicrobial Stewardship Programme in improving the use of antibiotics and outcomes of surgical patients in a tertiary hospital in Malaysia, Consultant, 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Strengthening Epidemic Intelligence in Malaysia, Principal Investigator(PI), 2011 - 2011, , (University)
  • Diseases among poverty (A community based participatory action research project), Co-Investigator, 2011 - 2012, HTMC, Flag ship, (National)
  • A Multicentre Study To Validate The Predictive Value Of Warning Signs In Dengue, Co-Investigator, 2011 - 2011, WHO, (International)
  • A phase 2B multicenter, randomized, comparative trial of UK-453.061 versus etravirine in combination with Darunavir/Ritonavir and a Nucleotide/Nucleoside reverse transcriptase inhibitor for the treatment of antiretroviral experienced HIV-1 infected subjects with evidence of NNRTI 0resistant HIV-1. A phase 2B/3 open-label rollover study for subjects discontinuing from the UK-453,061 protocols for the treatment of HIV-1 infected subjects. Sponsor : Pfizer, Principal Investigator(PI), 2010 - 2012, Pfizer, (National)
  • A prospective observational cohort study of immune reconstitution and its consequences in immunodeficient HIV-infected patients treated with highly active anti-retroviral therapy., Co-Investigator, 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Social Determinants Epidemiological Routes of HIV/STI transmission Among Fishermen, Principal Investigator(PI), 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • A Randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Combinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study, Co-Investigator, 2008 - 2008, NCHECR, University of New South Wales , (National)
  • International Collaboration on Endocarditis (ICE) Prospective Cohort Study of Infective Endocarditis, Co-Investigator, 2008 - 2008, ICE, (National)
  • A randomized, open label, comparative multicenter study of voriconazole versus conventional amphotericin B followed by fluconazole in the treatment of candidaemia in non neutropaenic subjects, Co-Investigator, 2008 - 2008, PFIZER Inc, (National)
  • An open non-comparative, multicentre study to assess the efficacy and safety of oral SB 265805 320 mg once daily for 7 days for the treatment of lower respiratory tract infections in adults. Sponsor: Smith-Kline Beecham International, Co-Investigator, 2008 - 2008, Smith-Kline Beecham International, (National)
  • Pilot Project: Introducing Methadone and HAART for Soon To Be Released HIV-Positive Prisoners in Pengkalan Chepa Kelantan, Co-Investigator, 2008 - 2008, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia Sponsor: National Institutes on Drug Abuse, USA, Principal Investigator(PI), 2008 - 2008, National Institutes on Drug Abuse, USA, (National)
  • ZEPHYR study, Principal Investigator(PI), 2008 - 2008, Pharmaceutical company (Pfizer), (International)
  • Genotypic and Phenotypic Characterization of Novel Human Immunodeficiency Virus Type 1 (HIV-1) Circulating Recombinant Form (CRF33_01B) in Malaysia, Principal Investigator(PI), 2007 - 2008, ScienceFund, (International)
  • Monitoring and Evaluation of HIV Drug Resistance in Patients on Antiretroviral Therapy. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER M., Co-Investigator, 2006 - 2008, TREAT Asia, (International)
  • A randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Conmbinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study, Principal Investigator(PI), 2006 - 2012, NCHECR, University of New South Wales, (International)
  • Evaluation of Transmitted HIV Drug Resistance in Treatment Na ve, Recently Infected HIV Individuals. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER S, Co-Investigator, 2006 - 2008, TREAT Asia, (International)
  • A randomized, controlled, open label-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment- experienced HIV-infected subjects Protocol: TMC114-214, Co-Investigator, 2005 - 2008, Tibotec, (International)
  • International collaborative study on epidemiological survey of HIV infections, isolation and characterisation of unique HIV-1 recombinants emerging in Malaysia., Principal Investigator(PI), 2005 - 2008, Japan Foundation for AIDS Prevention, (International)
  • Immune Reconstitution Disease in Severely Immuno- deficient AIDS patients commencing HAART Collaborator: University of Western Australia, Principal Investigator(PI), 2004 - 2008, University of Western Australia, (International)
  • Linezolid In The Treatment of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus Protocol: A5951001, Consultant, 2004 - 2008, Pfizer, (International)
  • A prospective randomized, double-blind, placebo- controlled, dose ranging, multi-center study of the safety and efficacy of three days continuous intravenous infusion of GR270773 in the treatment of suspected or confirmed gram negative severe sepsis in adults, Co-Investigator, 2004 - 2008, GSK, (International)
  • A Multi-faceted Study of HIV in Malaysia CIPRA R03 AI 56379-01, Principal Investigator(PI), 2003 - 2008, National Institute of Health, USA, (International)
  • TREAT Asia Observational Database, Co-Investigator, 2003 - 2008, amfAR, (International)
  • LY333328 versus vancomycin in complicated skin/skin-structure infections. Protocol H4Q-MC-ARRI, Co-Investigator, 2001 - 2008, Eli - Lily, (International)
  • A cross sectional survey and prospective study on tuberculin skin reaction among healthcare workers at University Malaya Medical Centre, Co-Investigator, 2001 - 2008, Geran Penyelidikan Universiti Malaya (UMRG), (International)
  • Clinical impact of antimicrobial resistance among invasive pneumococcal pathogens in Asian countries, Co-Investigator, 2000 - 2008, ANSORP, (International)
  • A Phase 111 study comparing the antiviral efficacy and safety of BMS-232632 with efavirenz, each in combination with fixed dose zidovudine-lamivudine, Co-Investigator, 2000 - 2008, Bristol-Myers Squibb, (International)
  • Prophylactic versus pre-emptive therapy of cytomegalovirus infection in bone marrow and solid organ transplant patients, Principal Investigator(PI), 1999 - 2008, IRPA, (International)
  • Efficacy and Safety of Oral Gatifloxacin versus oral amoxacillin with a treatment duration of 7 to 10 days in patients with bacterial community acquired pneumonia, Co-Investigator, 1999 - 2008, Grunenthal Gmbh, (International)
  • A Phase 1B Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV Positive Patients with No Previous Antiretroviral Therapy, Co-Investigator, 1999 - 2008, Sarawak Medichem Pharmaceuticals, (National)

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).


  • WHO 2013 Consolidated guidelines on the use of antiretroviral for the treatment and prevention of HIV, 2013-2013, WHO
  • Consultation on Ethics in Conducting Research in People Who Use Drugs- UNAIDS. Istanbul, 2010-2010, UNAIDS
  • Consultation on Ethics in Conducting Research in People Who Use Drugs 2 - UNAIDS, WHO. Kuala Lumpur , December 2010, 2010-2010, WHO
  • Confronting HIV among people who Inject Drugs - Kuala Lumpur Dec 09, 2009-2009, Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015
  • Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015 Confronting HIV Among People Who Inject Drugs Kuala Lumpur, 2009-2009, -
  • Global Advocacy for Injecting Drug Use Bill and Melinda Gates Foundation, London, 2008-2008, Bill and Melinda Gates Foundation
  • World Health Organisation. HIV Testing and Counselling. Phnom Penh, 2007-2007, World Health Organisation
  • World Health Organisation. HIV Testing and Counselling in IDU. Manila, 2007-2007, World Health Organisation
  • Institute of Medicine, National Academies of Sciences, USA. Prevention of HIV Infection among Injecting Drug Users in High Risk Countries An Assessment of the Evidence., 2005-2005, Institute of Medicine, National Academies of Sciences, USA
  • Antibiotics prescribing practices of upper respiratory tract infections in primary care, 2003-2003, MOSTI
  • ASEAN Workshop for the Exchange of Information on Increasing Access to HIV/AIDS Drug, 2002-2002, ASEAN
  • ASEAN Workshop for the Exchange of Information on Increasing Access to HIV/AIDS Drug, 2002-2002, APCASO
  • ASEAN Workshop for the Exchange of Experience on Increasing Access to Treatment and Care for PLWHA, 2002-2002, APCASO
  • United Nations General Assembly Special Session on HIV/AIDS, 2001-2001, United Nations
  • UK Department for International Development HIV-AIDS Project. Towards a Strategy for Commonwealth Universities Geneva., 2001-2001, Association of Commonwealth Universities
  • Special Session on HIV/AIDS. New York., 2001-2001, United Nations General Assembly
  • ASEAN Forum on HIV/AIDS. Port Dickson., 2001-2001, Ministry of Health Malaysia
  • Workshop on Notifiable Diseases., 2000-2000, Ministry of Health Malaysia
  • WHO Global Strategy for Containment of Antimicrobial Resistance Geneva., 2000-2000, World Health Organisation
  • Visiting Consultant Physician, 2000-2000, Institut Jantung Negara

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).


  • University Malaya, University Malaya, 2017, (University)
  • , Sultan Perak, 2016, (State)
  • Honarary Doctorates, Monash University, 2015, (International)
  • Certificate of Excellent Service, University Malaya, 2014, (University)
  • Top Research Scientists Malaysia, Akademi Sains Malaysia, 2014, (National)
  • Certificate of Credentialing & Privileging, University Malaya, 2013, (University)
  • UM Excellence Award, Naib Canselor, 2012, (University)
  • Sijil Penghargaan - Jawatankuasa Majlis Penilaian Teknologi Kesihatan Dan Panduan Amalan Klinikal, Kementerian Kesihatan Malaysia, 2012, (National)
  • Anugerah Cermerlang Universiti Malaya 2012, University Malaya, 2012, (University)
  • Australian Education Achievement Award 2012 ( Winner - Alumni Category ), Australian High Commissioner, Kuala Lumpur, 2012, (International)
  • Certificate of Excellent Service, University Malaya, 2011, (University)
  • Finalis Anugerah Perdana Menteri Penggiat Sosial Wanita 2011, Menteri Pembangunan Wanita, Keluarga Dan Masyarakat, 2011, (National)
  • 50 Emerging Women Leader in Asia Pacific 2011 Advance Australia, Australian Government, 2011, (International)
  • Pingat Bakti Setia Jabatan Penjara Malaysia, Jabatan Penjara Malaysia, 2009, (National)
  • Excellence Service Award, University Malaya, 2008, (University)
  • Merdeka Award, Exxon Mobil, Petronas and Shell, 2008, (National)
  • Tun Mahathir Science Award, Malaysian Academy of Science, 2008, (National)
  • Certificate of Excellent Service, University Malaya, 2007, (University)
  • Certificate of Excellent Service, University Malaya, 2006, (University)
  • Excellence Service Award, University Malaya, 2005, (University)
  • Swarovski Life Ball Crystal of Hope Award, Austrian Life Ball, 2005, (International)
  • Australian-Asian Fellowship Award, Australian Government, 2002, (International)
  • International Aids Fellowship Programme, International Society of Infectious Diseases, 1999, (International)
  • Fellow in Infectious Diseases, Senior Medical Staff, Fairfield Hospital, 1995, (International)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).


INVITED SPEAKER
  • Carbapenem-resistant Pseudomonas and Acinetobacter, 13th International Congress in Infectious Diseases (ICID). Kuala Lumpur, 2008-06-23 to  , International Society of Infectious Diseases, (International)
  • Monash University Malaysia Graduation Address, Monash University Malaysia Graduation Address, 2010-04-10 to 2010-04-10, Monash University , (International)
  • HIV Prevention in Malaysia, Global Health Centre, Columbia University, Almaty, Kazakshtan. May 2010. HIV Prevention in Malaysia, 2010-05-31 to 2010-05-31, Columbia University, (International)
  • , 5th National Conference for Clinical Research 2011, 2011-06-22 to 2011-06-24, Ministry of Health Malaysia, (National)
  • HIV and AIDS in Muslim Countries, Women In Science and Technology in Muslim Countries , 2011-09-21 to  , MOSTI, (National)
  • HIV care under universal coverage:challenges and choices, Global Public Health International Symposium on "Universal Coverage", 2011-10-03 to 2011-10-01, Monash University, (International)
  • HIV and Mobility, Asia Pacific Conference in Medical Virology 2012 , 2012-06-06 to 2012-06-08, APCMV 2012 Congress, (International)
  • AIDS in Asia at the symposia on HIV , 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID) , 2012-10-25 to 2012-10-28, 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID) , (International)
  • Viral Hepatitis and HIV Coinfection, Singapore AIDS COnference, 2012-11-17 to 2012-11-17, Singapore AIDS Conference, (International)
  • International Collaboration & Getting to Zero, 26th Annual Japan HIV Conference , 2012-11-24 to 2012-11-26, Japanese Society for AIDS Research, (International)
  • Accreditation on Medical School, Summit on Medical Education 2013, 2013-08-23 to 2013-08-23, University Teknologi MARA, (National)
  • , 7th National Infectious Diseases Seminar and Workshop (NIDSAW)2012, 2013-11-06 to 2013-11-06, Universiti Putra Malaysia, (National)
  • Towards A Unified Approach to Patient Safety : The ASEAN Perspective, 1st ASEAN Patient Safety Congress, 2015-06-25 to 2015-06-26, UP College of Medicine
  • Malaysian Society for Molecular Biology and Biotechnology, 22nd Annual MSMBB Scientific Meeting, 2015-09-08 to 2015-09-09, Malaysian Society for Molecular Biology and Biotechnology, (National)
  • Population Approach to HIV Prevention & Control, The 5th AHLA International Health Literacy Conference, 2017-11-12 to 2017-11-14, Centre for Population Health (CePH), Dept of Social and Preventive Medicine, Faculty of Medicine, UM, (National)
PRESENTER
  • , Islam and HIV/AIDS International Conference 2012, 2013-11-19 to 2013-11-21, Department of Islamic Development Malaysia, (National)
  • Two decades of harm reduction in Malaysia, The 27th IFNGO World Conference, 2017-11-06 to 2017-11-08, IFNGO - International Federation of Non - Government Organizations for the Prevention of Drug and Substance Abuse, (International)
PLEANARY/KEYNOTE SPEAKER
  • Substance Abuse and Harm Reduction, XVII International AIDS Conference August 2008. Mexico City., 2008-08-01 to  , (International)
INVITED SEMINAR
  • , The First ASEANS Deans' Summit : Connecting ASEAN Medical Schools towards One Community" - International Conference in Medicine and Public Health (ICMPH) 2012, 2012-09-17 to 2012-09-17, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, (International)
  • , Seminar on Rights and Responsibilities of Government Doctors, 2012-11-03 to 2012-11-03, SCHOMOS / MOH, (National)
OTHERS
  • International Experience of Harm Reduction, Xth International Conference of Drug Dependence. Xian, China. October 2008, 2008-10-01 to  , The Chinese Society of Addiction Medicine , (International)
  • Scalling up Harm Reduction in Malaysia, XIII th International Congress of AIDS in Asia and the Pacific (ICAAP)Aug 2009, 2009-08-01 to  , AIDS Soceity Asia Pacific, (International)
  • Substance Abuse and Harm Reduction in Malaysia, XV111 International AIDS Conference July 2010. Vienna. Substance Abuse and Harm Reduction in Malaysia, 2010-07-17 to 2010-07-24, International AIDS Society, (International)
  • Respondent Driven Sampling Involving the Community, XV111 International AIDS Conference July 2010. Vienna. Respondent Driven Sampling Involving the Community, 2010-07-17 to 2010-07-24, International AIDS Society, (International)
  • , MMA SECOND SEMINAR ON POSTGRADUATE MEDICAL EDUCATION, 2013-01-26 to 2013-01-26, Malaysian Medical Association, (National)

EXPERT LINKAGES
(Linkages Description), (Organisation), (Year of Involvement), (Duration), (Level).


  • Co-chairperson, Scientific Program Committee International AIDS Conference, Vienna 2010, International AIDS Society , 2010, 24, (International)
  • Member, Oversight Committee for the Second Independent Evaluation of UNAIDS, UNAIDS, 2008, 24, (International)
  • Executive Committee Member, International Society for Infectious Diseases (ISID), 2008, (International)
  • Member, United Nations Reference Group on HIV and Injecting Drug Use, United Nations , 2007, 24, (International)
  • Member, United Nations Regional Task Force on HIV Prevention in Injecting Drug Users, United Nations, 2006, 24, (International)
  • Advisory Board Member, International Harm Reduction Development, International Harm Reduction Development, 2006, 24, (International)
  • Vice-Chair, Global Initiatives Committee- Foundation for AIDS Research (amfAR), amfAR, 2006, 24, (International)
  • Advisory Board Member, UNAIDS Interagency Reference Group for the Technical Support Facility in Southeast Asia and the Pacific, UNAIDS, 2006, 24, (International)
  • Executive Committee Member, International Harm Reduction Association, International Harm Reduction Association, 2006, 24, (International)
  • Steering Committee Member, Asian Network on Surveillance of Resistant Pathogens (ANSORP), ANSORP, 2005, 24, (International)
  • Steering Committee Member. TREAT Asia. Regional Cooperative Network on Research and Therapeutics in HIV/AIDS. American Foundation for AIDS Research (amfAR), amfAR, 2005, 24, (International)
  • Member, Technical Expert Panel - UNAIDS Regional Task Force on IDU, consultative meeting, UNAIDS, 2005, (International)
  • Co-Chairperson - Consensus meeting on the use of antiretroviral therapy in Malaysia, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 2001, (National)
  • Member, Expert Panel - National Consensus Guidelines for the Management of Extended-spectrum Beta-Lactamase Producing Bacteria, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 2001, (National)
  • Chairperson - Consensus Guidelines on the management of Staphylococcus aureus infections, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 1999, (National)
  • Member, Expert Panel - Consensus on the use of antiretroviral therapy in emerging nations, BMS, 1998, (International)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).


  • Country Coordinating Mechanism , The Malaysian Global Fund, Country Coordinating Mechanism , The Malaysian Global Fund, Vice Chair / Member, 2009-Present, (National)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).


  • Speciality Subcommittee Infectious Disease - Committee Member, (National), 04/01/2016 until 03/01/2018
  • Angggota Majlis Penasihat Program Jelajah Kaseh Orang Muda OKB derma Organ Demi Kehidupan, (National), 24/07/2015 until  
  • Perlantikan sebagai External Reviewer bagi garis panduan Antibiotik Kebangsaan 2014, (National), 17/12/2014 until  
  • 20th International AIDS Conference Melbourne, Australia - Editors Reviewers, (International), 20/07/2014 until 25/07/2014
  • Ahli Majlis Perubatan Malaysia, (National), 22/12/2013 until 21/12/2016
  • Ahli Panel Pakar Bidang Perubatan Dan Sains Kesihatan, (National), 19/02/2013 until 18/02/2015
  • Subspeciality Training Subcommittee, (Government), 28/09/2012 until 27/09/2014
  • National Specialist Register, (National), 20/06/2012 until  
  • Panel Penilai Pakar untuk Penilaian Permohonan Pembiayaan dan Pemantauan Dana R, D&C Kementerian Sains, teknologi dan Inovasi (MOSTI), (National), 01/03/2012 until 31/12/2015
  • Executive Committee, Malaysian AIDS Council, (National), 01/01/2010 until 31/12/2016
  • Vice-Chair, Country Coordinating Mechanism, The Malaysian Global Fund Initiative ., (National), 01/01/2009 until 31/07/2009
  • Member, National Health Promotions Board, (National), 01/01/2008 until 01/04/2010
  • Malaysian AIDS Foundation - Chairman, (National), 01/01/2006 until 31/12/2016
  • President Malaysian AIDS Council, (National), 01/01/2006 until 01/04/2010
  • Member, National Infection Control and Antibiotic Committee, Ministry of Health, (National), 01/01/2005 until  
  • Member, National Task Force on Harm Reduction, Ministry of Health Malaysia, (National), 01/01/2005 until  
  • Convenor, Malaysian Harm Reduction Working Group, (National), 01/01/2004 until  

SUPERVISION


POST GRADUATE STUDENT
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Completed
  • Master Degree, Dr Leong Chee Loong, ADVANCED TRAINING IN INFECTIOUS DISEASES, 2008/2009
  • Master Degree, Dr James Koh, ADVANCED TRAINING IN INFECTIOUS DISEASES, 2008/2009
  • Master Degree, Dr Sufian Adnan, MMed, 2008/2009
  • Doctoral Degree (phd), Tee Kok Keng, PhD, 2008/2009
  • Master Degree, Dr Sufian Adnan, MMed, 2007/2008
  • Master Degree, Dr Sufian Adnan, MMed, 2006/2007
  • Master Degree, Dr Muhammad Zainafyah Bin Zakaria, MMed, 2004/2005
  • Master Degree, Dr Wong Chew Ming, MMed, 2004/2005

Ongoing
  • Doctoral Degree (phd), Tan Hong Yien, PhD, 2009/2010
  • Master Degree, Martin Choo, MSC, 2009/2010
  • Doctoral Degree (phd), Yong Yean Kong, PhD, 2009/2010
  • Master Degree, Tunku Noor Hayati Binti Tunku Abdul Rahman, MSC, 2009/2010
  • Doctoral Degree (phd), Dr Salwa Mudddthir Ismail Norien, PhD, 2009/2010
  • Master Degree, Dr Azureen Azmel, MMed, 2008/2009